Michael L Levitz insider trades: Anika Therapeutics (ANIK) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
39 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 11, 2022 | ANIK | ↑ Buy | 4,000 | $24.62 | $98K | Direct | Mar 14, 2022 (3d) |
| Aug 12, 2021 | ANIK | ↑ Buy | 3,627 | $40.21 | $146K | Direct | Aug 13, 2021 (1d) |
| Feb 27, 2019 | PODD | ↓ Sell10b5-1 | 1,350 | $92.01 | $124K | Direct | Feb 28, 2019 (1d) |
| Apr 2, 2015 | ALOG | ↓ Sell | 18,262 | $88.18 | $1.6M | Direct | Apr 3, 2015 (1d) |
| Apr 1, 2015 | ALOG | ↓ Sell | 959 | $90.39 | $87K | Direct | Apr 2, 2015 (1d) |
| Mar 18, 2015 | ALOG | ↓ Sell | 959 | $85.19 | $82K | Direct | Mar 19, 2015 (1d) |
| Mar 4, 2015 | ALOG | ↓ Sell | 959 | $87.30 | $84K | Direct | Mar 5, 2015 (1d) |
| Feb 18, 2015 | ALOG | ↓ Sell | 959 | $84.09 | $81K | Direct | Feb 19, 2015 (1d) |
| Feb 4, 2015 | ALOG | ↓ Sell | 959 | $82.51 | $79K | Direct | Feb 5, 2015 (1d) |
| Jan 21, 2015 | ALOG | ↓ Sell | 959 | $85.22 | $82K | Direct | Jan 23, 2015 (2d) |
| Jul 9, 2014 | ALOG | ↓ Sell | 652 | $76.67 | $50K | Direct | Jul 9, 2014 (0d) |
| Jul 2, 2014 | ALOG | ↓ Sell | 825 | $78.44 | $65K | Direct | Jul 3, 2014 (1d) |
| Jun 25, 2014 | ALOG | ↓ Sell | 651 | $76.34 | $50K | Direct | Jun 27, 2014 (2d) |
| Jun 18, 2014 | ALOG | ↓ Sell | 660 | $75.69 | $50K | Direct | Jun 19, 2014 (1d) |
| Jun 11, 2014 | ALOG | ↓ Sell | 660 | $75.28 | $50K | Direct | Jun 13, 2014 (2d) |
| May 21, 2014 | ALOG | ↓ Sell | 666 | $75.23 | $50K | Direct | May 22, 2014 (1d) |
| May 14, 2014 | ALOG | ↓ Sell | 666 | $74.63 | $50K | Direct | May 15, 2014 (1d) |
| May 7, 2014 | ALOG | ↓ Sell | 700 | $71.66 | $50K | Direct | May 8, 2014 (1d) |
| Apr 30, 2014 | ALOG | ↓ Sell | 651 | $75.51 | $49K | Direct | May 2, 2014 (2d) |
| Apr 23, 2014 | ALOG | ↓ Sell | 804 | $80.44 | $65K | Direct | Apr 24, 2014 (1d) |
| Apr 16, 2014 | ALOG | ↓ Sell | 804 | $81.16 | $65K | Direct | Apr 17, 2014 (1d) |
| Apr 9, 2014 | ALOG | ↓ Sell | 787 | $82.61 | $65K | Direct | Apr 10, 2014 (1d) |
| Apr 2, 2014 | ALOG | ↓ Sell | 795 | $81.78 | $65K | Direct | Apr 3, 2014 (1d) |
| Mar 26, 2014 | ALOG | ↓ Sell | 817 | $79.83 | $65K | Direct | Mar 28, 2014 (2d) |
| Mar 19, 2014 | ALOG | ↓ Sell | 802 | $80.83 | $65K | Direct | Mar 20, 2014 (1d) |
| Mar 12, 2014 | ALOG | ↓ Sell | 831 | $78.50 | $65K | Direct | Mar 14, 2014 (2d) |
| Mar 5, 2014 | ALOG | ↓ Sell | 786 | $95.41 | $75K | Direct | Mar 7, 2014 (2d) |
| Feb 26, 2014 | ALOG | ↓ Sell | 778 | $96.79 | $75K | Direct | Feb 27, 2014 (1d) |
| Feb 19, 2014 | ALOG | ↓ Sell | 759 | $98.00 | $74K | Direct | Feb 20, 2014 (1d) |
| Feb 12, 2014 | ALOG | ↓ Sell | 773 | $96.80 | $75K | Direct | Feb 13, 2014 (1d) |
| Dec 20, 2013 | ALOG | ↓ Sell | 171 | $88.43 | $15K | Direct | Dec 23, 2013 (3d) |
| Nov 15, 2013 | ALOG | ↓ Sell | 162 | $92.48 | $15K | Direct | Nov 18, 2013 (3d) |
| Oct 18, 2013 | ALOG | ↓ Sell | 162 | $93.49 | $15K | Direct | Oct 21, 2013 (3d) |
| Sep 20, 2013 | ALOG | ↓ Sell | 183 | $82.50 | $15K | Direct | Sep 23, 2013 (3d) |
| Aug 16, 2013 | ALOG | ↓ Sell | 166 | $75.19 | $12K | Direct | Aug 19, 2013 (3d) |
| Jul 19, 2013 | ALOG | ↓ Sell | 144 | $69.66 | $10K | Direct | Jul 22, 2013 (3d) |
| Jun 21, 2013 | ALOG | ↓ Sell | 170 | $73.90 | $13K | Direct | Jun 24, 2013 (3d) |
| May 17, 2013 | ALOG | ↓ Sell | 185 | $80.89 | $15K | Direct | May 20, 2013 (3d) |
| Jan 15, 2013 | ALOG | ↓ Sell | 553 | $75.16 | $42K | Direct | Jan 16, 2013 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ANIK insiders
Open-market trades in the last 12 months
About Michael L Levitz's insider trades
Michael L Levitz is EVP, CFO, Treasurer at Anika Therapeutics (ANIK). Since Jan 15, 2013, Michael has reported 2 open-market purchases worth $244K and 37 sales worth $3.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (3% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (19 filings), shares withheld for taxes (18 filings), option exercises (17 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.